A new Annals of Internal Medicine podcast episode has Dr. Centor discussing where tirzepatide fits in type 2 diabetes treatment.
Recap by typeshit. Post by @annalsofim on Instagram.
An explainer on how GLP-1 drugs act on reward and craving in the brain, and the research testing them against alcohol, nicotine and other substance use.
Dr Alo, a cardiologist, says he is following the cardiovascular data on these drugs closely and that it is shifting how heart disease is treated.
Robert Lufkin MD shares the observational data: an average 16.1 kg lost at six months among 7,297 women, with 62.7% reporting side effects.
50:28
DOWNSIZED looks at why appetite and food noise can creep back late in the weekly cycle, and what that may say about whether a GLP-1 is still working.
The clinic points to work by Diogo Pinto da Costa Viana and colleagues on how tirzepatide may interact with progestogen pills taken as part of hormone therapy.
A 2022 PLOS ONE study found 63.2% of people reported needle phobia. BioNxt is working on a sublingual semaglutide film, though such formats aren't FDA approved.
Loading…